EX-23.1 4 igms-ex231_397.htm EX-23.1 igms-ex231_397.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement No. 333-233826 on Form S-8 of our report dated March 26, 2020, relating to the financial statements of IGM Biosciences, Inc., appearing in this Annual Report on Form 10-K for the year ended December 31, 2019.

 

//s// Deloitte & Touche

 

San Francisco, California

 

March 26, 2020